Generic News 7.16.15

Author: APCI Staff/Thursday, July 16, 2015/Categories: Generics and Vendor Contracting, Generic Bulletins

**GENERIC SPECIALS - DEEP DISCOUNTS **

"Weekly Generics Campaign"

LOOK for DEEP Discounts with APCI's Weekly Generics Campaign!

Regular ordering through McKesson - discount price will be in place during campaign period.

Items on the Generics Campaign this week:

Effective for orders placed 7/09/15 – 07/15/15

ITEM# NDC DESC TOP 250 CAMPAIGN DATES INVOICE DATES
1398288 228277811 PROPRAN ER 60MG N 7/16/15 - 7/22/15 7/17/15 -7/23/15
1913391 168016246 CLOBETA PR OI 0.05% N 7/16/15 - 7/22/15 7/17/15 -7/23/15
1432905 16714036304 TRI-LN TB.18MG/.035MG6X28 N 7/16/15 - 7/22/15 7/17/15 -7/23/15
1396282 603243321 BENZTROP TB 0.5MG 100 N 7/16/15 - 7/22/15 7/17/15 -7/23/15

Antipyrine Otic was previously scheduled for this week’s campaign has since been removed from the formulary due to vendor not able to supply – sorry for the loss of this product – our sourcing team is working to get a replacement soon!

2481539 ANTIPYRINE OTIC SOL B&L 10ML@ not on campaign

Watch for these Items on Generics Campaign NEXT week:

ITEM# NDC DESC TOP 250 CAMPAIGN DATES INVOICE DATES
2156743 55111025660 ZIPRASID CAP 20MG N 7/23/15 - 7/29/15 7/24/15 - 7/30/15
1139781 781502207 METHYLPRED TAB 4MG Y 7/23/15 - 7/29/15 7/24/15 - 7/30/15
2026979 55111053405 DIVALPROEX ER 500MG Y 7/23/15 - 7/29/15 7/24/15 - 7/30/15
2028371 65862056090 PANTOPRAZOL DR 40MG 90 Y 7/23/15 - 7/29/15 7/24/15 - 7/30/15
1890805 49884060511 LAMOTRIG ER TAB 300MG PAR 30@ N 7/23/15 - 7/29/15 7/24/15 - 7/30/15

Check out a full list of Custom Discounted Items our website weekly - updated every Monday!

https://www.apcinet.com/AboutUs/Services/VendorContracting/APCIDiscountedGenerics/tabid/535/Default.aspx


NEWS YOU CAN USE

Generic Launches

Launch of generic Namenda® IR

Amneal launched the generic equivalent of Namenda IR (memantine HCl). The Amneal items will be added to the APCI Formulary program in the A-slot, with visibility in McKesson Connect Saturday, July 11, 2015. Estimated U.S. brand sales of Namenda IR are approximately $2.8B.

There will be an ASAP/ASAP+ for this launch. ASAP+ shipments will begin next week and be completed by Monday, July 20th.

Product Launch Information – OneStop Add
Bx Name Namenda IR
Bx Supplier Actavis
Generic Name memantine HCl
Generic Description 2 strengths – 5mg and 10mg Tablets
Therapeutic Class/Indication 289200-CENTRAL NERVOUS SYSTEM AGENTS, MISC. / indicated for the treatment of moderate to severe dementia of the Alzheimer's type.
FDA Approval Date 4/10/2015
Launch Reason Settlement
Launch Exclusivity No
Number of Players 4+
US Brand Sales $2.8B

To order, please use the following item numbers:

Item # Supplier Name NDC Description OS ADD
3468139* AMNEAL PHARMACEUTICALS 53746016930 MEMANTINE HCI TAB 10MG AMN 30 07/11/2015
3468121 AMNEAL PHARMACEUTICALS 53746017360 MEMANTINE HCI TAB 5MG AMN 60 07/11/2015

*Please note, the 10mg generic item launched as a 30-count bottle, rather than a 60-count bottle.

**We want to be sure customers are aware you will be receiving your price protected ASAP+ shipments so that you do not proactively purchase inventory before the shipments arrive.


Launch of Generic Targretin®

Mylan launched the generic equivalent of Targretin Capsules® (bexarotene). The Mylan item will be added to the OneStop program in the A slot, with visibility in McKesson Connect on Friday, July 10, 2015. Estimated U.S. brand sales of Targretin are approximately $10M. There will be NOT be ASAP & ASAP+ for this launch.

Product Launch Information – Formulary Add
Bx Name Targretin Capsules
Bx Supplier Valeant
Generic Name bexarotene
Generic Description 75 mg 100 count
Indication Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
FDA Approval Date 8/12/2014
Launch Reason Settlement
Launch Exclusivity Yes
Number of Players 1
US Brand Sales $10M

To order, please use the following item numbers:

Item # Supplier Name NDC Description OS ADD
3466307 MYLAN PHARMACEUTICALS 00378695501 BEXAROTENE CAP 75MG MYL 100 7/10/2015

For questions please contact ISManagement@McKesson.com.


Launch of Generic Axert®

Patriot launched the generic equivalent of Axert® (almotriptan malate). The Patriot item will be added to the APCI Formulary program in the A slot, with visibility in McKesson Connect on Wednesday, July 8, 2015. Estimated U.S. brand sales of Axert® are approximately $51M.

To order, please use the following item numbers:

Item # Supplier Name NDC Description MS ADD
3459799 PATRIOT PHARMACEUTICALS 10147096101 ALMOTRIP MAL TB 12.5MG PAT 2X6 07/08/2015
3459773 PATRIOT PHARMACEUTICALS 10147096201 ALMOTRIP MAL TB 6.25MG PAT 1X6 07/08/2015

For questions please contact ISManagement@McKesson.com


Service Level Watchlist

Watchlist as of July 12, 2015

SL Item Item NDC Description Supplier OS Slot Update
AZITHROMYCIN
  2046845 63739057510 AZITHROMY TAB 250MG UD SKY100@ SKY PHARMACEUTICAL A NO RELEASE DATE
BENZONATATE
* 3247475 65162053710 BENZONATATE CAP 200MG AKY 100@ AMNEAL/AKYMA PHARMA A PRODUCT AVAILABLE
  1340934 65162053750 BENZONATATE CP 200MGAMN 500@ AMNEAL/AKYMA PHARMA A NO RELEASE DATE
BUPROPION HCL
* 1806314 185111160 BUPROPIO ER TAB 200MG SAN 60@ SANDOZ PHARMACEUTICALS A AVAILABLE LATE JULY 2015
* 1204577 185041560 BUPROPIO ER TB 150MG SAN 60@ SANDOZ PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  2137446 47335073886 BUPROPIO ER TAB 200MG CARA 60@ CARACO PHARMACEUTICALS A/C AVAILABLE LATE JULY 2015
  1257542 185041501 BUPROPIO ER TAB 150MG EON 100@ SANDOZ PHARMACEUTICALS A AVAILABLE EARLY AUGUST 2015
  1439405 185041552 BUPROPIO ER TAB 150MG SAN 250@ SANDOZ PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  1215128 185041505 BUPROPIO ER TAB 150MG SAN 500@ SANDOZ PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  2137370 47335073788 BUPROPIO ER TB 150MG CARA 100@ CARACO PHARMACEUTICALS A/C AVAILABLE IN LIMITED QUANTITY IN LIMITED DCs
  2137354 47335073786 BUPROPIO ER TAB 150MG CARA 60@ CARACO PHARMACEUTICALS A/C AVAILABLE IN LIMITED QUANTITY IN LIMITED DCs
  2137495 47335073713 BUPROPIO ER TB 150MG CARA 500@ CARACO PHARMACEUTICALS A/C AVAILABLE IN LIMITED QUANTITY IN LIMITED DCs
CYCLOBENZAPRINE HCL
* 1149483 50111056301 CYCLOBENZ TAB 10MG TEVA 100@ TEVA PHARMACEUTICALS A TO BE DISCONTINUED
  1361955 50111056303 CYCLOBENZ TAB 10MG TEVA 1000@ TEVA PHARMACEUTICALS A TO BE DISCONTINUED
DICYCLOMINE HCL
* 1979467 378162001 DICYCLOM TAB 20MG MYL 100@ MYLAN PHARMACEUTICALS A AVAILABLE LATE JULY 2015
EPINEPHRINE
* 1990654 54505010202 EPINEPH INJ 0.3MG AMED 2@ AMEDRA SPECIALTY GX (FORMERLY CORE) A AVAILABLE EARLY AUGUST 2015
  2580157 54505010201 EPINEPH AUTO INJ 0.3MG AMED@ AMEDRA SPECIALTY GX (FORMERLY CORE) A/C AVAILABLE EARLY AUGUST 2015
ETHOSUXIMIDE
* 3219359 61748002501 ETHOSUX CAP 250MG VERS 100@ VERSAPHARM INC A AVAILABLE EARLY AUGUST 2015
FELODIPINE
* 1399252 53489036901 FELODIP ER TAB 5MG MUT 100@ MUTUAL/SCH A AVAILABLE LATE JULY 2016
FLUOXETINE HCL
* 2474674 93718856 FLUOXET TAB 10MG TEV 30@ TEVA PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  3000346 93718810 FLUOXET HCL TAB 10MG TEV1000@ TEVA PHARMACEUTICALS A AVAILABLE IN LIMITED DCs
HYDROCHLOROTHIAZIDE
* 2058584 16729018201 HYDROCHL TAB 12.5MG ACC 100@ ACCORD A AVAILABLE IN LIMITED QUANTITY
KETOCONAZOLE
* 1641919 781709004 KETOCONAZOLE SHAM 2% SAN 4OZ@ SANDOZ PHARMACEUTICALS A AVAILABLE LATE JULY 2015
LITHIUM CARBONATE
* 2106961 68462022401 LITHIUM CARB ER 450MG GLEN100@ GLENMARK PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  2065332 68084065501 LITHIUM TAB 450MG UD AHP 100@ AMERICAN HEALTH PACKAGING A NO RELEASE DATE
LOPERAMIDE HCL
* 1622117 93031101 LOPERAM CAP 2MG TEV 100@ TEVA PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  1622232 93031105 LOPERAM CAP 2MG TEV 500@ TEVA PHARMACEUTICALS A AVAILABLE MID AUGUST 2015
MIRTAZAPINE
  1254663 63739035610 MIRTAZAP TAB 30MG UD SKY10X10@ SKY PHARMACEUTICAL A NO RELEASE DATE
MUPIROCIN CALCIUM
* 1902840 66993094215 MUPIROCIN CM 2% PRAS 15G@ PRASCO LABORATORIES A AVAILABLE LATE JULY 2015
TAMOXIFEN CITRATE
* 1106681 378027493 TAMOXIFEN CITR TB 20MG MYL 30@ MYLAN PHARMACEUTICALS A AVAILABLE LATE JULY 2015
  1112879 378027401 TAMOXIFEN CITR TB 20MG MYL100@ MYLAN PHARMACEUTICALS A TO BE DISCONTINUED
TEMAZEPAM
  1254960 63739023110 TEMAZEP CAP 15MG UD SKY 10X10@ SKY PHARMACEUTICAL A AVAILABLE IN LIMITED DCs
TRAMADOL HCL
* 3209277 49884082111 TRAMADOL ER TAB 100MG PAR 30@ PAR PHARMACEUTICAL INC A/C AVAILABLE MID JULY 2015
VENLAFAXINE HCL
* 2135010 93738456 VENLAF ER CP 37.5MG TEV 30@ TEVA PHARMACEUTICALS A/C AVAILABLE LATE AUGUST 2015
  3436797 904646861 VENLAF ER CP UD37.5MGMMP10X10@ MAJOR PHARMACEUTICAL A/C AVAILABLE IN LIMITED DCs
  2151934 59762018003 VENLAF ER CP37.5MG UDGRE10X10@ GREENSTONE LIMITED A/C AVAILABLE IN LIMITED DCs

Drug Supply Chain Security Act

The Drug Supply Chain Security Act (DSCSA) was signed into law on November 27, 2013, as Title II of the Drug Quality and Security Act of 2013. DSCSA creates national requirements for tracing pharmaceuticals across the supply chain, preempting any state-level requirements associated with the Prescription Drug Marketing Act of 1987. This includes provisions for product identification, tracing and verification, detection and response, notification, wholesaler licensing, and third-party logistics provider licensing.

DSCSA provides consistency of traceability on a national scale. Full implementation within the next 10 years will result in standardized, unit-level traceability from the manufacturer to the pharmacy/practitioner – the entire supply chain.

Upcoming DSCSA milestones include:

January 1, 2015

  • All suppliers must send to McKesson: transaction history (TH), transaction information (TI), and transaction statement (TS) data for all pharmaceutical products. McKesson must provide this transaction record data to its customers. All customers which function as distributors must do the same for their respective customers.
  • All customers are responsible for monitoring/reporting any suspect/illegitimate products in the supply chain.

July 1, 2015

  • McKesson Distribution Center (DC) Purchases: McKesson will retain customer data for purchases from McKesson Distribution Centers for six years.
  • Non-McKesson DC Purchases: Pharmacies must begin retaining TH, TI and TS data for six years.

Please contact your McKesson Sales Representative if you have questions or need additional information regarding DSCSA.

To run the Traceability reports in Connect go to:

Business Management Programs > Reports > Traceability Reporting >

Enter Account information and other data to run the report


APCI APPROVED VENDORS


Comments are only visible to subscribers.